CPT® (CDT codes and descriptions are copyright American Dental Association) | |
---|---|
86901 | |
86900 | |
ICD-10-CM | |
E72.12 | Methylenetetrahydrofolate reductase deficiency |
Order Code Order Code Name Order Loinc Result Code Result Code Name UofM Result LOINC; 010181: Beta-2 Microglobulin, Serum: 1952-1: 010181: Beta-2 Microglobulin, Serum: mg/L: 1952-1
Apr 12, 2022 · a.k.a. B2M, Serum beta-2 microglobulin, β2-Microglobulin, B2M, Serum, Serum B2M. reference ranges for test results (normal, abnormal, etc.) web resources - additional online information about the test. search by test name, synonym, LOINC code, disease or CPT/ICD code. This product also includes Laboratory Decision System (LDS) rankings.
Oct 01, 2021 · R77.1 is a billable/specific ICD-10-CM code that can be used to indicate a diagnosis for reimbursement purposes. The 2022 edition of ICD-10-CM R77.1 became effective on October 1, 2021. This is the American ICD-10-CM version of R77.1 - other international versions of ICD-10 R77.1 may differ. Applicable To Hyperglobulinemia NOS
Beta-2-Microglobulin, Serum - Beta-2-microglobulin normally passes through the glomerulus into the proximal tubule where much of it is reabsorbed. Serum levels are therefore an index of glomerular function. When impaired, serum levels rise in inverse ratio to glomerular filtration rate. Increased amounts of beta-2-microglobulin are excreted in several renal disorders, e.g., Balkan …
B2M is a type of tumor marker. Tumor markers are substances made by cancer cells or by normal cells in response to cancer in the body. B2M is found on the surface of many cells and is released into the body. Healthy people have small amounts of B2M in their blood and urine.Dec 10, 2020
Beta-2 microglobulinB2MAliasesB2M, entrez:567, IMD43, beta-2-microglobulin, Β2 microglobulinExternal IDsOMIM: 109700 MGI: 88127 HomoloGene: 2987 GeneCards: B2MshowGene location (Human)showGene location (Mouse)16 more rows
Other specified abnormal immunological findings in serumICD-10 code R76. 8 for Other specified abnormal immunological findings in serum is a medical classification as listed by WHO under the range - Symptoms, signs and abnormal clinical and laboratory findings, not elsewhere classified .
R76.8Code R76. 8 other specified abnormal immunological findings in serum for a positive tTG or DMG test. All positive and indeterminate coeliac serology tests are typically followed by an intestinal biopsy. A biopsy is the only method to make a definitive diagnosis of coeliac disease.
The amount of beta-2-microglobulin in the blood....The Revised International Staging System.RISS Stage GroupFactorsIIISerum beta-2 microglobulin is 5.5 (mg/L) or greater AND Cytogenetics are considered “high-risk”* AND/OR LDH levels are high2 more rows•Feb 28, 2018
Beta globulins are a group of globular proteins in plasma that are more mobile in alkaline or electrically charged solutions than gamma globulins, but less mobile than alpha globulins. Examples of beta globulins include: beta-2 microglobulin.
A53. 9 is a billable/specific ICD-10-CM code that can be used to indicate a diagnosis for reimbursement purposes. The 2022 edition of ICD-10-CM A53.
59 (Encounter for screening for other viral diseases), which the CDC previously said should be used when patients being screened for COVID-19 have no symptoms, no known exposure to the virus, and test results that are either unknown or negative.Dec 21, 2020
ICD-10 | Other fatigue (R53. 83)
Presence of the tissue transglutaminase (tTG) IgA antibody is associated with glutensensitive enteropathies such as celiac disease and dermatitis herpetiformis. tTG IgA antibody concentrations greater than 40 U/mL usually correlate with results of duodenal biopsies consistent with a diagnosis of celiac disease.
ICD-10 | Celiac disease (K90. 0)
Ankylosing spondylitis of unspecified sites in spine M45. 9 is a billable/specific ICD-10-CM code that can be used to indicate a diagnosis for reimbursement purposes. The 2022 edition of ICD-10-CM M45. 9 became effective on October 1, 2021.
Why do I need a beta-2 microglobulin tumor marker test? You may need this test if you have been diagnosed with multiple myeloma, lymphoma, or leukemia. The test can show the stage of your cancer and whether your cancer treatment is working.
What happens during a beta-2 microglobulin tumor marker test? A beta-2 microglobulin test is usually a blood test, but may also be given as a 24-hour urine test, or as a cerebrospinal fluid (CSF) analysis. For a blood test, a health care professional will take a blood sample from a vein in your arm, using a small needle.
This test measures the amount of a protein called beta-2 microglobulin (B2M) in the blood, urine, or cerebrospinal fluid (CSF). B2M is a type of tumor marker. Tumor markers are substances made by cancer cells or by normal cells in response to cancer in the body. B2M is found on the surface of many cells and is released into the body.
B2M levels are sometimes measured to: Check for kidney damage in people with kidney disease. Find out if a viral infection, such as HIV/AIDS, has affected the brain and/or spinal cord.
This may mean your cancer is spreading, and/or your treatment is not working. Your B2M levels are decreasing. This may mean your treatment is working.
B2M is found on the surface of many cells and is released into the body. Healthy people have small amounts of B2M in their blood and urine. People with cancers of the bone marrow and blood often have high levels of B2M in their blood or urine. These cancers include multiple myeloma, lymphoma, and leukemia.
A B2M tumor marker test is not used to diagnose cancer. But it can provide important information about your cancer, including how serious it is and how it may develop in the future. Other names: total beta-2 microglobulin, β2-microglobulin, B2M.
Clinical Information. Beta-2-microglobulin (beta-2-M) is a small membrane protein (11,800 Dalton) associated with the heavy chains of class I major histocompatibility complex proteins and is, therefore, on the surface of all nucleated cells. The small size allows beta-2-M to pass through the glomerular membrane, ...
In a study of pretreatment serum beta-2-M levels in 100 patients with myeloma it was reported that the median survival of patients with values >4 mcg/mL was 12 months , whereas median survival for patients with values <4 mcg/mL was 43 months.
The small size allows beta-2-M to pass through the glomerular membrane, but it is almost completely reabsorbed in the proximal tubules. Serum beta-2-M levels are elevated in diseases associated with increased cell turnover.
Specimens received in a non-Beta-2 Microglobulin transport tube with a pH less than 6 • Any volume other than 10 mL urine in the transport tube • Any specimen with pH less than 6
Beta-2-Microglobulin, Urine - Beta-2-Microglobulin (B2M) is a low molecular weight protein that forms the light chain component of the histocompatibility antigen. It is synthesized by all nucleated cell types. It is an integral part of the class I MHC antigens and is present in all body fluids. B2M is filtered through the glomeruli ...